Inactivation of Human Immunodeficiency Virus Type I in Human Milk: Effects of Intrinsic Factors in Human Milk and of Pasteurization

Journal of Human Lactation

Volumn 9, Issue 1, 1993, Pages 13-17

  Orloff, S L ^a   Wallingford, J C ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

HIV; human milk; pasteurization

Indexed keywords

ARTICLE; BREAST MILK; DISINFECTION; HEALTH CARE FACILITY; HEAT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROBIOLOGY; STANDARD;

DISINFECTION; EVALUATION STUDIES; HEAT; HIV-1; HUMAN; MILK, HUMAN; TISSUE BANKS;

EID: 0027571384     PISSN: 08903344     EISSN: 15525732     Source Type: Journal    
DOI: 10.1177/089033449300900125     Document Type: Article

References (17)

1. Thiry L, Sprecher-Goldberger S, Jonckheer T, et al: Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet 2: 891-892, 1985
2. Vogt MW, Witt DJ, Craven DE, et al: Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Lancet 1: 525-527, 1986
3. Oxtoby MJ: Human immunodeficiency virus and other viruses in human milk: placing the issues in broader perspective. Pediatr Infec Dis J 7: 823-835, 1988
4. Hira SK, Mangrola UG, Mwale C, et al: Apparent vertical transmission of human immunodeficiency virus type 1 by breast-feeding in Zambia. J Pediatr 117: 421-424, 1990
5. Van de Perre P, Simonon A, Msellati P, et al: Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 325: 593-598, 1991
6. Baumslag N: Breast-feeding and HIV infection. Lancet 2: 401-401, 1987
7. McDougal JS, Martin LS, Cort SP, et al: Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus III/lymphadenopathy-associated virus, with special reference to antihemophilic factor. J Clin Invest 76: 875-877, 1985
8. Martin LS, McDougal JS, Loskoski SL: Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy-associated virus. J Infec Dis 152: 400-403, 1985
9. Resnick L, Veren K, Salahuddin SZ, et al: Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. J Am Med Assoc 255: 1887-1891, 1986
10. Eglin RP, Wilinson AR: HIV infection and pasteurization of breast milk. Lancet 1: 1093-1093, 1987
11. Ford JE, Law BA, Marshall VME, et al: Influence of the heat treatment of human milk on some of its protective constituents. J Pediatr 90: 29-35, 1977
12. McDougal JS, Cort SP, Kennedy MS, et al: Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV). J Immunol Methods 76: 171-183, 1985
13. Centers for Disease Control: Recommendations for assisting in the prevention of perinatal transmission of human-T-lymphotropic virus type III/LAV. MMWR 34: 721-732, 1985
14. Sarkar NH, Charney J, Dion AS, et al: Effect of human milk on the mouse mammary tumor virus. Cancer Res 33: 626-629, 1973
15. Welsch JK, Arsenakis M, Coelen RJ, et al: Effect of antiviral lipids, heat and freezing on the activity of viruses in human milk. J Infec Dis 140: 322-328, 1979
16. Kabara JJ: Lipids as host-resistance factors of human milk. Nutr Rev 38: 65-73, 1980
17. Thormar H, Isaacs CE, Brown HR, Barshatzky MR, et al: Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob Agents Chemother 31: 27-31, 1987